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a2 .2-Globulin Nephropathy in
White Ravens
In a recent article in Scientific American,
Woodward and Goodstein (1) discussed
the handling ofdata that do not support a
given hypothesis. They illustrated their
point as follows:
an investigator might inductively infer,
after observing a large number of black
ravens, that all ravens are black. According
to the inductive approach, good scientific
practice consists in recording all that one
observes and not just some selected part of
it. The guiding ideal is to avoid any error
that might slip in as a result ofprejudice or
preconception.
Later, the authors discussed the falsifi-
cationist ideas ofKarl Popper in relation to
the black ravens: "the observation ofa sin-
gle nonblack raven will falsify the hypothe-
sis that all ravens are black."
Huff (2) recently discussed the role of
cell proliferation in chemical carcinogene-
sis. At one point he discussed the ability of
certain putatively nongenotoxic chemicals
to induce renal cancer in male rats. The
section in question is worth quoting in frill.
Meanwhile regulators and administrators
should continue to be considerably cau-
tious before embracing a purported mecha-
nism-even a reasonable proposed hypo-
thetical mechanism of carcinogenesis-as
being pivotal to public health decisions.
One example still garnering considerable
debate centers on whether chemicals that
induce cancers of the tubular cell epitheli-
um ofthe kidney in male rats, concomitant
with an increase in cell proliferation and
testosterone-mediated ca-2p-globulin pro-
tein are relevant or useful to overall hazard
identification for humans. The U.S.
Environmental Protection Agency (for
example) has embraced the concept that
these experimental carcinogenic responses
are not important to the human situation,
whereas others (e.g., the Interational
Agency for Research on Cancer) appear
properly cautious, or have proposed equally
reasonable alternative hypotheses. For
example, and yet to be clarified, there are
several chemicals known to induce this spe-
cific nephropathy syndrome that do not
cause kidney cancers, and may or may not
produce cancers in other organs; this lack
ofconsistency must be explained.
Huff has seen some white ravens, but
he has not identified them for other inter-
ested parties to study. I too have heard
similar rumors, but I have yet to see a con-
vening of the chemical structure, genetic
toxicity, hyalin droplet data, and adequate
rat cancer bioassay data for such a chemi-
cal. Given the importance of the issue
under discusion, it would be valuable if
Huff were to identify the chemicals to
which he referred and present the relevant
data for them in a focused paper. This
would enable the commissioning of
research to elucidate whether the a2p-
globulin male rat renal cancer hypothesis
should be retained or abandoned. Equally,
when the available data are scrutinized,
and perhaps extended, it may be possible
to retain the hypothesis for use under qual-
ified conditions; for example, it may be
concluded that the persistence or magni-
tude ofthe nephropathy, as opposed to its
presence, is the critical parameter.
The surest way to make progress in
assessment of the hazard posed to humans
by rodent carcinogens is for exceptions to
current models to be clearly identified and
made the subject ofactive research. In the
absence of a range ofvalid models, there
will be only one: namely, that the rodent
carcinogens dibenzanthracene and sodium
saccharin present the same intrinsic car-
cinogenic hazard to humans.
JohnAshby
Zeneca Central Toxicology Laboratory
Alderley Park, Cheshire, United Kingdom
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Response: a2p-Globulin
Nephropathy, Posed
Mechanisms, and White
Ravens
In our zest to discover the holy grail(s) of
chemical carcinogenesis-read mecha-
nism(s)-we seem to have short circuited
the time-honed pattern of Koch's path of
finding/proving scientific truth. As I
understand the scientific paradigm of dis-
covery, one must exhaust and counter all
possible exceptions to the purported
hypothesis before accepting the conjecture
as truth. Further, if one exception to the
rule persists-white ravens-then the
hypothesis is either untrue or, at the most,
must be modified to accommodate the
uncertainty introduced by the exception. If
several and varied exceptions exist, then
the putative mechanism must be aban-
doned or be considered very limited in
validity or application. Ashby (1) proposes
that "it may be possible to retain the
hypothesis for use under qualified condi-
tions." Ideally, I have little difficulty with
his suggestion; however, in practice, the
workability of such nuances is nearly
impossible. Recall that "as it happens often
in science, a timid suggestion at the end of
a discussion, a carefully worded hypothesis,
become transformed in the next paper
(often by other authors) into a fact" (2).
Perhaps this is what happened to the a2p-
globulin hypothesis, without the attendant
necessary search for white ravens. Some
have associated this testosterone-mediated
protein with tumors ofthe kidney-in male
rats. Importantly, a plausible rationale has
yet to be offered to explain why certain
a2p-globulin-provoking chemicals fail to
systematically induce renal tubular cell
tumors. Early on, in fact, several ofus have
raised basic issues about this purported
mechanism (3-5).
Hence, from my personal perspective
in the sensitive area of human health and
life, one must ignore the scientific urge to
retain such tentative and "footnoted"
hypotheses because proof, acceptance, and
utilization for public health purposes must
remain sacrosanct and on a firm founda-
tion, especially when the use ofsaid limit-
ed proofallows greater potential risks to be
propagated or perpetrated. Nonetheless,
the search for mechanisms ofcarcinogene-
sis-likely to be chemical specific-must
continue.
In this vein, Ashby (1) urges me to
identify the white ravens in the a2p-globu-
lin story. As that earlier paper, from which
Ashby generously quotes my writing, was a
more broadened view of the visible white
ravens in the overall hypothesis of chemi-
cally induced cell proliferation and cancer
(6), I did not identify the specific chemical
exceptions to the a2p-globulin hypothesis.
I had given the names of those chemicals
in previous papers (7,8) and did not think
them particularly relevant in the cell prolif-
eration paper quoted by Ashby. Further, I
certainly believed that those professing the
strength of the a2p-globulin hypothesis
would have been aware of these excep-
tions-aware ofthem and either explained
the discrepancies or simply discounted
them. In this communication, the chemi-
cals that disobey the a2p-globulin hypoth-
esis are given.
I am pleased for the opportunity to list
these chemicals, together with brief
explanatory passages for each. So far, there
are at least four chemicals that instigate the
a2p-globulin-syndrome yet do not induce
tumors of the kidney in male rats:
gabapentin, an antiepileptic drug; lindane,
an insecticide; decalin, a solvent; and
trimethylpentane, the prototypical a2p-
globulin inducer present in gasoline.
Additionally, another chemical induces the
a2p-globulin sequela but causes two differ-
ent cellular rypes of tumors of the kidney
(dimethyl methylphosphonate). One
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chemical has similar a2p-globulin respons-
es in both control and exposed animals (t-
butyl alcohol); another chemical induces
a2p-globulin, yet causes the same renal
tubular cell tumors in both sexes (hexa-
chlorobenzene).
Importantly, two additional chemicals
presumed to involve a2p-kidney tumors
(and thus are regarded by some as irrele-
vant to humans) have now been shown to
be associated with kidney cancers in
humans: gasoline (9,10) and trichloroeth-
ylene (TCE) (11,12). Actually, TCE, one
ofseveral chlorinated hydrocarbon solvents
once predicted and thought to activate this
syndrome, has not been shown to induce
a2p-globulin, but is interesting to mention
simply for historical completeness. Another
solvent linked to human cancers, per-
chloroethylene, causes renal tubular cell
tumors at concentrations that neither
increase protein droplets nor accumulate
a2p-globulin in proximal tubules of male
rats (4). Ifreaders are aware ofother chem-
ical exceptions, these should be document-
ed and reported as well.
Gabapentin. In long-term feeding
experiments, gabapentin caused adenomas
and adenocarcinomas of the pancreas in
male rats (13,14). Also, this chemical has
been reported to induce a2p-globulin; yet,
the predicted renal tubular cell tumors
were not found in these studies (15).
Maintenance antiepileptic doses for this
therapeutic agent range from 1,200 to
2,400 mg/day, but "the dose required to
achieve control of seizures may be much
higher" (16). Thus, doses of gabapentin
may be as high as 50-100 mg/kg in
humans, not far removed from the lowest
dose causing tumors in animals.
Lindane. The y-isomer of hexachloro-
cyclohexane, lindane, induces a2p-globu-
lin nephropathy (17) without causing
tumors ofthe kidney in long-term carcino-
genicity studies (18). Tumors of the liver
in mice and of the thyroid gland in rats
were induced following long-term expo-
sure to lindane (18-20).
Decalin. Decalin is probably the first
chemical for which no empirical connec-
tion could be made between induced hya-
line droplet-a2p-globulin nephropathy
syndrome and cancer of the renal tubular
epithelial cells (21). In these experiments,
male and female Fischer 344 rats and
female C57BI/6 mice were exposed to
decalin vapor at concentrations of 0, 5, or
50 ppm for 13 weeks, followed by a 19-
month observation period. After 13 weeks
ofexposure to decalin, male rats exhibited
the classical a2ji-globulin nephropathy,
characterized by hyaline droplets, necrosis,
and intratubular casts. At the end of the
post-exposure period, male rats exhibited
dose-related chronic progressive necrosis
with accentuated tubular degeneration,
medullary mineralization, and papillary
hyperplasia; however, no tumor ofthe kid-
ney was reported for male rats or for any
other sex-species-exposure group.
Whether this exposure regimen was rig-
orous enough to make decalin the first a2p-
globulin-associated nonkidney carcinogen
remains to be confirmed. Yet, until ongoing
experiments by the National Toxicology
Program using both Fischer and NBR rats
are completed and reported, this conclusion
would appear reasonable, given that the
a2p-globulin-syndrome was extant and
chronic nephropathy was dose related at the
end of the 22-month experiments.
Moreover, as evidence of a carcinogenesis
experiment, incidences of tumors of the
pituitary gland were increased in male rats
and in female mice.
Trimethylpentane. Isooctane (2,2,4-
trimethylpentane; TMP) is a major compo-
nent in gasoline and the putative a2p-glob-
ulin inducer thought to impart the observed
carcinogenicity to gasoline (22). Activity
resides apparently in the TMPOH metabo-
lite (2,4,4-trimethyl-2-pentanol). What is
interesting in this scenario is that TMP, the
prototypical a2p-globulin inducer, had not
been tested for carcinogenicity during the
time much of the mechanistic effort was
going on. Thus, one did not know ifTMP
would in fact be the agent responsible for
the gasoline-induced kidney toxicity and
carcinogenicity in male rats or liver tumors
in mice (7).
Now this chemical has been evaluated
by the Instituto Ramazzini for carcino-
genicity in a long-term bioassay, and the
finding is that trimethylpentane is not car-
cinogenic for the kidney or for any other
organ in male or female Sprague Dawley
rats exposed to this chemical for their life
time (F. Belpoggi, personal communica-
tion). And the observed nephropathy was
typical of what is seen in these aged rats.
Thus, not only do these negative findings
make one further question the canon of
2a2p-globulin inducers per se in the car-
cinogenic process, but also places full
doubt on the identity of the causative
agent in gasoline responsible for tumors of
the kidney and liver.
Dimetlhylmethylphosphonate. Dimethyl
methylphosphonate (DMMP), used as a
flame retardant and as a nerve gas simu-
lant, was given by gavage for 2 years to
F344 rats and to B6C3F1 mice (23,24).
These authors concluded that
The spectrum ofkidney lesions seen in the
male rat given DMMP is similar to that
seen after the long-term administration ofa
variety of other chemicals including
unleaded gasoline, hydrocarbon solvents,
and 1,4-dichlorobenzene.
The authors go on to suggest that the
kidney le,sions were associated with hyaline
droplet nephropathy and, although not
measured, specifically to (x2p-globulin.
Two observations tend to complicate
this notion: first, DMMP induced hyper-
plasia ofthe tubular and ofthe transitional
cell epithelium (the latter not ordinarily
associated with a2p-globulin), and second,
DMMP caused not only tubular cell ade-
nocarcinomas but also transitional cell
papillomas and carcinomas (the latter
tumors not ordinarily associated with a2p-
globulin). Logically then, because this
combination oflesions and kidney tumors
have never occurred in tandem with
respect to a2p-globulin, one might sup-
pose that dual mechanisms are at play. Or
one might parlay that DMMP alone
caused these lesions and the co-occurrence
of a2p-globulin is mechanistically irrele-
vant, simply being a coincidental biomark-
er of exposure or a carrier molecule as
some have proposed (3-5). In any event,
more effort needs to be directed towards
understanding the mechanism(s) underly-
ing this duality phenomenon.
t-ButylAkohol t-Butanol (TBA), used
in making perfumes and cosmetics, causes
increased formation of hyaline droplets in
the kidneys of male rats (25,26). TBA did
induce kidney tumors, yet the coincidental
occurrence ofother lesions in both controls
and exposed animals makes one pause in
declaring this association as causal.
Interestingly, as in DMMP, TBA induces
hyperplasia of transitional epithelial cells in
addition to the typical ex2p-globulin
nephropathy. Also, TBA causes tumors of
the thyroid gland in mice, another new find-
ing for a2p-globulin chemicals. Suspicion
about this posed mechanism is also raised by
the observations of similar toxicity in both
controls and exposed male rats: mineraliza-
tion, severity of nephropathy, and renal
tubular cell hyperplasia. The obvious ques-
tions are why the controls exhibit toxicities
ofthekidneyverysimilar to theexposed ani-
mals although they were not exposed to
TBA or why the exposed animals only had
lesions similar in severity and incidence to
the controls. This could mean no more than
a typical late stage nephropathy seen in most
male rats, and in these studies, female rats
also exhibitedend-stagenephropathy.
Using step-sectioning of the kidney,
tubular cell tumors were found in 16% of
controls versus 25%, 38%, and 26% ofthe
three TBA-dosed groups of animals. The
only apparent difference between controls
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and treated male rats was the occurrence of
hyaline droplets, which did not induce any
concomitant differences in toxicity and
only a marginal difference in tumor inci-
dence. In fact, standard sectioning revealed
one renal tumor in controls versus three,
four, and three in TBA animals, not an
overwhelming response, especially if one
looks at the results to confirm the role of
a2p-globulin in the carcinogenesis process.
Hexachlorobenzene. Hexachlorobenzene
(HCB) is an example of a chemical that
induces the a2p-globulin nephropathy
syndrome in male and female Sprague
Dawley rats (27) and causes cancer in sev-
eral species [rat, liver and kidney (28);
hamster, liver and thyroid gland (29);
mouse, liver (29)] and in a two-generation
study in rats, parathyroid and adrenal
glands (20,30). HCB is the first chemical
identified that exhibits the a2p-globulin
nephropathy sequelae, and induces renal
cell tumors in both genders ofrats.
Tubular cell tumors ofthe kidney were
found more often and apparently earlier in
male rats than in females (28). In these
HCB studies, even lower exposure regi-
mens would have likewise been associated
with renal tumor induction, especially in
males. In females, one might view the dose
response-tumor induction pattern as being
perfectly correlated with chemical exposure
(that is, double the exposure concentration
and double the tumor response) although
tumor rates were not age-adjusted for pos-
sible differences in survival (28). Further,
three types of the liver tumors were
observed in HCB-exposed Sprague Dawley
rats, with females being more responsive
than males. Whether competing risk fac-
tors or the commonly later-occurring kid-
ney tumors in females influenced these
numerical differences of HCB-induced
renal carcinogenesis remains to be ascer-
tained.
Using two protocols (100 mg/kg/day
for 15 days and 50 mg/ kg/day for 50
days), Bouthillier et al. (27) observed only
in males degenerative and regenerative cel-
lular foci, along with accumulation ofpro-
tein droplets, in epithelial cells ofthe prox-
imal tubules in both HCB experiments.
Renal functional alterations were seen with
the longer exposure. a2p-Globulin was
increased 11-fold in male rats compared to
controls (apparently not measured in
females), and HCB was found to be bound
reversibly to a2fp-globulin. Authors con-
clude "that HCB induces a male rat specif-
ic nephropathy that could explain the
higher incidence ofkidney tumors in male
rats compared to female rats," and "protein
droplets ... are considered to represent the
initial step toward specific kidney tumor
formation in male rats compared to female
rats" (27).
Because HCB induces tumors of the
kidney in female as well as in male rats (by
different mechanisms? and do these differ-
ent mechanisms influence renal tumor
induction and incidence in male rats, too?)
and HCB induces various and unusual
tumor types at high incidences in both sexes
ofthree rodent species, other interpretations
must be considered. Alternate theories have
been proposed (3-5) and more research
needs to be done before one continues to
discount chemical-induced tumors in the
male rat kidney as being irrelevant for
assessing risksposed to humans.
For example, Fowler and DuVal (30)
have identified a specific cleavage product
of a2p-globulin as the high affinity lead-
binding protein responsible for deposition
oflead in the kidney ofmale rats. A simi-
larly functioning protein has been demon-
strated in human kidney (31). This human
lead-binding protein has mass and charge
similar to that ofthe a2p-globulin detect-
ed in rat kidney; however, the two proteins
apparently differ in immunological reactiv-
ity. Thus, chemicals (or metabolites) that
inducea2li-globulin nephropathy and kid-
ney cancer in male rats may logically cause
kidney toxicity and/or carcinogenesis in
humans after reacting with the lead-bind-
ing protein or by another mechanism. Of
course, this assumes one accepts both pur-
ported mechanisms.
Of the chemicals observed to induce
hyaline droplets in NTP long-term studies,
only d-limonene caused the singular occur-
rence of tubular cell neoplasms without
also inducing other neoplastic responses in
male or female rats or mice. Therefore,
only one ofthe chemicals we have studied
that induce hyaline droplets is exclusively a
male rat kidney carcinogen (3,32). This is
important in understanding the mechanis-
tic pathways for the carcinogenic responses
associated with these chemicals and per-
mits the likelihood that a chemical may
have multiple mechanisms, oralternatively,
it may indicate that binding to a2p-globu-
lin has little mechanistic function other
than to locate and retain the chemical or
metabolite in the kidney. Further, the great
majority ofchemicals that exhibit a gender
difference in the induction ofkidney can-
cers has not been shown to increase a2p-
globulin accumulation in the kidney;
therefore, the bases for the higher preva-
lence of tumors ofthe kidney in male rats
has not been established. Likewise in
humans, kidney tumors develop more fre-
quently in males than in females (3,7).
Short (33), for instance, citing his work
andothers, suggests that
similar correlative studies with a number of
other renal carcinogens and noncarcinogens
arewarranted before general conclusions can
be made. Cell proliferation is excessively ele-
vated in tubules affected bychronic progres-
sive nephropathy, but the significance ofthe
lesion to renal carcinogenesis is unclear.
Elucidating mechanisms ofrenal cell prolif-
eration are necessary for our understanding
ofcause andeffect relationships.
And cell proliferation is only a part of the
multistage process ofcarcinogenesis (6,34).
In 1969, Foulds (35) provided us with
an insightful cautionary note that may be
relevant today in our quest for defining
mechanisms ofcarcinogenesis:
One of the greatest evils in modern cancer
research is the abuse ofdefinitions that are
based on the preconceived ideas ofindivid-
ual investigators highly expert over an
extremely narrow range of neoplastic phe-
nomena . . .; they presume as axiomatic
what remains to be proved or, sometimes,
what has already been disproved.
Given the above exceptions to the rule,
perhaps a new look needs to be given to
the postulated association between a2p-
globulin production and renal tumors in
male rats and their relevance to public
health. After all, 1) the accumulated data
given above preclude any blanket endorse-
ment of the a2p-globulin-mechanism,
especially given that 2) so far, only one
chemical, d-limonene, has been associated
singularlywith the a2p-globulin syndrome
and kidney tumors in male rats, with no
other tumors in female rats or in male or
female mice; 3) in all cases that have been
proposed to evoke the a2p-globulin theo-
ry, none of the chemicals exhibit any
greater incidences ofrenal cell tumors than
do non-Xa2p-globulin inducing chemicals,
and most exhibit poor dose response
curves; and 4) the majority of chemicals
that preferentially cause tubular cell
tumors of the kidney predominantly in
male rats do not provoke a2p-globulin,
thus, not explaining the significant gender
differences in this and other chemically
induced specific organ site tumors (and in
humans as well). Regarding this last point,
i am convinced that ifbioassays were con-
ducted for longer periods of time, e.g.,
30-36 months, gender discrepancies for
tumors ofthe kidneywould become moot.
In our rightful quests to identify and
define mechanisms of chemical carcino-
genesis, we must remain vigilant during
our pursuit to overcome any tendency to
endorse or accept a mechanism before
incontrovertible proof exists. For instance,
early in the a2p-globulin metaphor, some
were proposing that chemicals shown to
induce cx2p-globulin in short-term studies
Volume 104, Number 12 December 1996 * Environmental Health Perspectives 1266Correspondence
need not be tested in long-term bioassays
because the results were predictable. This
has been disproved.
James Huff
National Institute ofEnvironmental
Health Sciences
Research Triangle Park, North Carolina
Iappreciate the comments andsuggestions made byJ
Carl Barrett, Douglas Bristol, John Bucher, and
RonaldMelnick.
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PBBs: Potential Effects in
Children
Colborn et al. (1) describe thyroid hor-
mone deficiency in Great Lakes salmon and
state that research has ruled out iodine defi-
ciency as the cause. Great Lakes herring
gulls also have enlarged thyroid glands; it
has been suggested that chemicals in the
lakes can block thyroid hormones, but a
specific chemical has not been identified. I
would like to call attention to the article by
Bahn et al. (2) in which the authors
describe cases of primary hypothyroidism
in men employed in the manufacture of
polybrominated biphenyls (PBBs). The
observation ofthyroid abnormalities in ani-
mals exposed to PBBs and PBB oxides sup-
ports the hypothesis that exposure to PBBs
or other brominated compounds is causally
related to the hypothyroidism in these men.
Perhaps the thyroid deficiencies observed in
Great Lakes salmon and herring gulls are a
result of the large-scale contamination of
the Michigan environment with PBBs in
the early 1970s. Furthermore, dairy cattle
were thought to be suffering from an ail-
ment similar to iodine toxicity early in the
PBB contamination episode (3). Perhaps
the halogenated chemicals have similar
actions. It has been suggested that the thy-
roid hormone deficiency may result from
the similarity in structure of thyroid hor-
mone and the biphenyl compounds; thus,
Environmental Health Perspectives * Volume 104, Number 12, December 1996 1267